361 Capital’s Imperva, Inc. IMPV Stock Holding History

361 Capital’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-33,067	Closed	-$1.43M	–	437
2018 Q1	$1.43M	Sell	33,067 -6,863	-17%	-$308K	0.35%	154
2017 Q4	$1.58M	Sell	39,930 -82	-0.2%	-$3.42K	0.39%	133
2017 Q3	$1.74M	Buy	+40,012	New	+$1.83M	0.33%	163

Other funds holding IMPV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

361 Capital's IMPV Position: Q2 2018 in Review

361 Capital sold out of Imperva, Inc. (IMPV) in Q2 2018, closing a stake of 33,067 shares — an estimated $1.43M sold.

361 Capital first reported a position in IMPV in Q3 2017 and held it in 3 quarters. The position peaked at $1.74M in Q3 2017. 188 funds tracked by Wall St. Rank hold IMPV as of Q2 2018.

361 Capital reported no remaining Imperva, Inc. position as of Q2 2018 after selling out during the quarter.
361 Capital sold 33,067 Imperva, Inc. shares in Q2 2018, an estimated $1.43M.
361 Capital first reported a position in Imperva, Inc. in Q3 2017 and held it in 3 quarters.
361 Capital's Imperva, Inc. position peaked at $1.74M in Q3 2017.
188 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.